These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 8387200

  • 1. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
    Sista ND, Pagano JS, Liao W, Kenney S.
    Proc Natl Acad Sci U S A; 1993 May 01; 90(9):3894-8. PubMed ID: 8387200
    [Abstract] [Full Text] [Related]

  • 2. Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha.
    Sista ND, Barry C, Sampson K, Pagano J.
    Nucleic Acids Res; 1995 May 25; 23(10):1729-36. PubMed ID: 7784177
    [Abstract] [Full Text] [Related]

  • 3. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.
    Holley-Guthrie EA, Quinlivan EB, Mar EC, Kenney S.
    J Virol; 1990 Aug 25; 64(8):3753-9. PubMed ID: 2164595
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F, Sergeant A, Corbo L.
    J Gen Virol; 1996 Mar 25; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [Abstract] [Full Text] [Related]

  • 5. Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions.
    Pfitzner E, Becker P, Rolke A, Schüle R.
    Proc Natl Acad Sci U S A; 1995 Dec 19; 92(26):12265-9. PubMed ID: 8618882
    [Abstract] [Full Text] [Related]

  • 6. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
    Wu FY, Wang SE, Chen H, Wang L, Hayward SD, Hayward GS.
    J Virol; 2004 May 19; 78(9):4847-65. PubMed ID: 15078966
    [Abstract] [Full Text] [Related]

  • 7. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
    Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL, Kenney SC.
    Nucleic Acids Res; 1993 Jul 11; 21(14):1999-2007. PubMed ID: 8393562
    [Abstract] [Full Text] [Related]

  • 8. Efficient transactivation by retinoic acid receptors in yeast requires retinoid X receptors.
    Heery DM, Zacharewski T, Pierrat B, Gronemeyer H, Chambon P, Losson R.
    Proc Natl Acad Sci U S A; 1993 May 01; 90(9):4281-5. PubMed ID: 8387213
    [Abstract] [Full Text] [Related]

  • 9. Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. Binding of ligands to RAR only is sufficient for RAR-RXR heterodimers to confer ligand-dependent activation of hRAR beta 2/RARE (DR5).
    Xiao JH, Durand B, Chambon P, Voorhees JJ.
    J Biol Chem; 1995 Feb 17; 270(7):3001-11. PubMed ID: 7852380
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
    Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A, Swenson J, Kenney S.
    J Virol; 2000 Feb 17; 74(3):1224-33. PubMed ID: 10627532
    [Abstract] [Full Text] [Related]

  • 11. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
    Taylor N, Flemington E, Kolman JL, Baumann RP, Speck SH, Miller G.
    J Virol; 1991 Aug 17; 65(8):4033-41. PubMed ID: 1649314
    [Abstract] [Full Text] [Related]

  • 12. EBV-immortalized isogenic human B-cell clones exhibit differences in DNA-protein complex formation on the BZLF1 and BRLF1 promoter regions among latent, lytic and TPA-activated cell lines.
    Cen H, McKnight JL.
    Virus Res; 1994 Jan 17; 31(1):89-107. PubMed ID: 8165871
    [Abstract] [Full Text] [Related]

  • 13. Interaction between retinoic acid and vitamin D signaling pathways.
    Schräder M, Bendik I, Becker-André M, Carlberg C.
    J Biol Chem; 1993 Aug 25; 268(24):17830-6. PubMed ID: 8394351
    [Abstract] [Full Text] [Related]

  • 14. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ, Mirocha SJ, Stephany HM, Puchalski JR, Mertz JE.
    J Virol; 2001 Jan 25; 75(2):867-77. PubMed ID: 11134300
    [Abstract] [Full Text] [Related]

  • 15. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
    Salbert G, Fanjul A, Piedrafita FJ, Lu XP, Kim SJ, Tran P, Pfahl M.
    Mol Endocrinol; 1993 Oct 25; 7(10):1347-56. PubMed ID: 8264664
    [Abstract] [Full Text] [Related]

  • 16. The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B.
    Gutsch DE, Holley-Guthrie EA, Zhang Q, Stein B, Blanar MA, Baldwin AS, Kenney SC.
    Mol Cell Biol; 1994 Mar 25; 14(3):1939-48. PubMed ID: 8114725
    [Abstract] [Full Text] [Related]

  • 17. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.
    Zalani S, Holley-Guthrie EA, Gutsch DE, Kenney SC.
    J Virol; 1992 Dec 25; 66(12):7282-92. PubMed ID: 1331521
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
    Sato H, Takeshita H, Furukawa M, Seiki M.
    J Virol; 1992 Aug 25; 66(8):4732-6. PubMed ID: 1321269
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation.
    Hong Y, Holley-Guthrie E, Kenney S.
    Virology; 1997 Mar 03; 229(1):36-48. PubMed ID: 9123876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.